Hepatograma alterado en pacientes con infección por HIV/SIDA

1. De Maat MM, Mathot RA, Veldkamp AI, et al. Hepatotoxicity following nevirapine-containing regimens in HIV-1-infected individuals. Pharmacol Res (England), Sep 2002, 46(3) p. 295-300

2. Puoti M, Torti C, Ripamonti D, et al.
Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome. J Acquir Immune Defic Syndr (United States), Mar 1 2003, 32(3) p259-67

3. Nowak P, Schvarcz R, Ericzon BG, et al.
Follow-up of antiretroviral treatment in liver transplant recipients with primary and chronic HIV type 1 infection. AIDS Res Hum Retroviruses (United States), Jan 1 2003, 19(1) p13-9

4. Sterling RK, Contos MJ, Sanyal AJ, et al.The clinical spectrum of hepatitis C virus in HIV coinfection. J Acquir Immune Defic Syndr (United States), Jan 1 2003, 32(1) p. 30-7

5. Pett SL, Dore GJ, Fielden RJ, et al.
Cyclical hepatitis and early liver cirrhosis after hepatitis C seroconversion during pulsed antiretroviral therapy for primary HIV-1. AIDS (England), Nov. 22 2002, 16(17) p. 2364-5

6. Blasko M Liver disease mortality in HIV-1 and hepatitis B coinfection Dtsch Med Wochenschr (Germany), Mar 7 2003, 128(10) p